Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus

Journal of Experimental Medicine

Volumn 185, Issue 2, 1997, Pages 207-218

  Morgenstern, David E ^a   Gifford, Mary A C ^a   Li, Ling Lin ^a   Doerschuk, Claire M ^b   Dinauer, Mary C ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CHRONIC GRANULOMATOUS DISEASE; HOST RESISTANCE; INFECTION RESISTANCE; LUNG ALVEOLUS MACROPHAGE; LUNG ASPERGILLOSIS; MACROPHAGE FUNCTION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

ANIMALS; ASPERGILLUS FUMIGATUS; CYTOKINES; GRANULOMATOUS DISEASE, CHRONIC; INFLAMMATION; LINKAGE (GENETICS); LUNG DISEASES; MACROPHAGES, ALVEOLAR; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; PHAGOCYTOSIS; RESPIRATORY BURST; X CHROMOSOME;

EID: 0031041884     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.2.207     Document Type: Article

References (47)

1. Dinauer, M.C. 1993. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. Crit. Rev. Clin. Lab. Sci. 30:329-369.
2. Carson, M.J., D.L. Chadwick, C.A. Brubaker, R.S. Cleland, and B.H. Landing. 1965. Thirteen boys with progressive septic granulomatosis. Pediatrics. 35:405-412.
3. Johnston, R.B., Jr., and J. McMurry. 1967. Chronic familial granulomatosis. Am. J. Dis. Child. 114:370-378.
4. Gallin, J.I., E.S. Buescher, B.E. Seligmann, J. Nath, T. Gaither, and P. Katz. 1983. Recent advances in chronic granulomatous disease. Ann. Intern. Med. 99:657-674.
5. Moskaluk, C.A., H.W. Pogrebniak, H.I. Pass, J.I. Gallin, and W.D. Travis. 1994. Surgical pathology of the lung in chronic granulomatous disease. Am. J. Clin. Pathol. 102:684-691.
6. Segal, A. 1996. The NADPH oxidase and chronic granulomatous disease. Mol. Med. Today. 2:129-135.
7. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to aspergillus. J. Clin. Invest. 69:617-631.
8. Dixon, D.M., A. Polack, and T.J. Walsh. 1989. Fungus dose-dependent primary pulmonary aspergillosis. Infect. Immun. 57:1452-1456.
9. Schaffner, A. 1985. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Invest. 76:1755-1764.
10. Sidranksy, H.E.V., and H. Beede. 1965. Experimental pulmonary aspergillosis. Arch. Pathol. 79:299-309.
11. Diamond, R.D., and R.A. Clark. 1982. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect. Immun. 38:487-495.
12. Diamond, R.D., R. Krzesicki, B. Epstein, and J. Wellington. 1978. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in Aspergillosis and Mucormycosis. Am. J. Pathol. 91:313-328.
13. Schaffner, A., H. Douglas, A.I. Braude, and C.E. Davis. 1983. Killing of aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 42:1109-1115.
14. Washburn, R.G., J.I. Gallin, and J.E. Bennett. 1987. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect. Immun. 55:2088-2092.
15. Pollock, J.D., D.A. Williams, M.A.C. Gifford, L.L. Li, X. Du, J. Fisherman, S.H. Orkin, C.M. Doerschuk, and M.C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
16. Arnovv, P.M., M. Sadigh, G. Costas, D. Weil, and R. Chudy. 1991. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. J. Infect. Dis. 164:998-1002.
17. Beaumont, F., H.F. Kauffman, H.J. Sluiter, and K. De Vries. 1984. Environmental aerobiological studies in allergic bronchopulmonary aspergillosis. Allergy (Cph). 39:183-193.
18. Wilkes, D.S., K.M. Heidler, L.K. Bowen, W.M. Quinlan, N.A. Doyle, O.W. Cummings, and C.M. Doerschuk. 1995. Allogeneic bronchoalveolar lavage cells induce the histology of acute lung allograft rejection, and deposition of IgG2a in recipient murine lungs. J. Immunol. 155:2775-2783.
19. Pollock, J., D. Williams, M. Gifford, L. Li, X. Du, J. Fisherman, S. Orkin, C. Doerschuk, and M. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocytes superoxide production. Nat. Genet. 9:202-209.
20. Doerschuk, C.M., R.K. Winn, H.O. Coxson, and J.M. Harlan. 1990. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J. Immunol. 144:2327-2333.
21. Kubo, H., D. Morgenstern, W. Quinlan, P. Ward, M. Dinauer, and C. Doerschuk. 1996. Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase. J. Clin. Invest. 97:2680-2684.
22. Ulich, T.R., Y. Songmei, K. Guo, E.S. Yi, D. Remick, and J. del Castillo. 1991. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol. 138:1097-1101.
23. Lee, J., G. Cacalano, T. Camerato, K. Toy, M.W. Moore, and W.I. Wood. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155:2158-2164.
24. Yoshimura, T., N. Yukhi, S.K. Moore, E. Appella, M.I. Lerman, and E.J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1). Full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244:487-493.
25. Curnutte, J. 1992. Disorders of granulocyte function and granulopoiesis. In Hematology of Infancy and Childhood, 4th ed. N. Oski, editor, W.B. Saunders Company, Philadelphia. 904-937.
26. Lehrer, R.I., and R.G. Jan. 1970. Interaction of Aspergillus fumigatus with human leukocytes and serum. Infect. Immun. 1:345-350.
27. Robertson, M.D., A. Seaton, L.J.R. Milne, and J.R. Raeburn. 1987. Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. Thorax. 42:466-472.
28. Lehmann, P., and L. White. 1975. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice. Infect. Immun. 12: 987-992.
29. Diamond, R.D., E. Huber, and C.C. Haudenschild. 1983. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. J. Infect. Dis. 147:474-483.
30. Eisenhauer, P.B., and R.I. Lehrer. 1992. Mouse neutrophils lack defensins. Infect. Immun. 60:3446-3447.
31. Denis, M. 1994. Human monocytes/macrophages: NO or no NO. J. Leukocyte Biol. 55:682-684.
32. Segal, A., M. Geisow, R. Garcia, A. Harper, and R. Miller. 1981. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature (Lond.). 290:406-409.
33. Clark, R.A., and S. Klebanoff. 1979. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J. Clin. Invest. 64:913-920.
34. Clark, R.A., S. Szot, K. Venkatasubramanian, and E. Schiffman. 1980. Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine. J. Immunol. 124: 2020-2026.
35. Weiss, S.J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-375.
36. Schreck, R., P. Rieber, and P.A. Baeurle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO (Eur. Mol. Biol. Organ.) J. 10:2247-2258.
37. Brumell, J.H., A.L. Burkhardt, J.B. Bolen, and S. Grinstein. 1996. Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J. Biol. Chem. 271: 1455-1461.
38. Staal, F.J.T., M. Roederer, L.A. Herzenberg, and L.A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor kappa β and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:9943-9947.
39. DeForge, L.E., A.M. Preston, E. Takeuchi, J. Kenney, L.A. Boxer, and D.G. Remick. 1993. Regulation of interleukin-8 gene expression by oxidant stress. J. Biol. Chem. 268:25568-25576.
40. Jackson, S.H., J.I. Gallin, and S.M. Holland. 1995. The p47phox knock-out model of chronic granulomatous disease. J. Exp. Med. 182:751-758.
41. Gallin, J.I., and E.S. Buescher. 1983. Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease. Inflammation. 7:227-232.
42. Quie, P.G., and K.K. Belani. 1987. Corticosteroids for chronic granulomatous disease. J. Pediatr. 111:393-394.
43. Bozic, C.R., L.F. Kolakowski, N.P. Gerard, C. Garcia-Rodriguez, C. von Uexkull-Gulenband, M.J. Conklyn, R. Breslow, H.J. Showell, and C. Gerard. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:6048-6057.
44. Ruiz-Herrera, J. 1967. Chemical components of the cell wall of Aspergillus species. Arch. Biochem. Biophys. 122:118-125.
45. Suzuki, K., Y. Okawa, K. Hashimoto, S. Suzuki, and M. Suzuki. 1984. Protecting effect of chitin and chitosan in experimentally induced murine candidiasis. Microbiol. Immunol. 28: 903-912.
46. Sherwood, E.R., D.L. Williams, R.B. McNamee, E.L. Jones, I.W. Browder, and N.R. Di Luzio. 1987. In vitro tumoricidal activity of resting and glucan-activated Kupffer cells. J. Leukocyte Biol. 42:69-75.
47. Boros, D.L. 1978. Granulomatous inflammations. Prog. Allergy. 24:183-267.